Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Biochemical Pharmacology
|
April 25, 2008
Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases
James P Hardwick
Liver Research
|
June 28, 2019
Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2
Yoon Kwang Lee, Jung Eun Park, Mikang Lee, et al.
Free Radical Biology & Medicine
|
March 5, 2013
Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury
Mohamed A Abdelmegeed, Sehwan Jang, Atrayee Banerjee, et al.
Advances in Pharmacology (San Diego, Calif.)
|
August 3, 2015
Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease
Byoung-Joon Song, Mohammed Akbar, Inho Jo, et al.
Drug Development Research
|
June 30, 2012
Purification and Recognition of Recombinant Mouse P2X(1) Receptors Expressed in a Baculovirus System
Liping Chen, James P Hardwick, Peter McPhie, et al.
PPAR Research
|
March 20, 2010
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
James P Hardwick, Douglas Osei-Hyiaman, Homer Wiland, et al.
Archives of Biochemistry and Biophysics
|
February 12, 2008
Genomic structure and regulation of the rat hepatic CYP4F1 gene by peroxisome proliferators
Ellen Donelson, Liping Chen, Xiaolan Zhang, et al.
Free Radical Biology & Medicine
|
June 23, 2009
Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress
Mohamed A Abdelmegeed, Kwan-Hoon Moon, James P Hardwick, et al.
Biochemical Pharmacology
|
November 19, 2021
CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD)
Nicholas Osborne, Charles Leahy, Yoon-Kwang Lee, et al.
Hepatology Communications
|
February 7, 2018
Hairy and enhancer of split 6 prevents hepatic lipid accumulation through inhibition of <i>Pparg2</i> expression
Jung Eun Park, Mikang Lee, Seong-Chul Kim, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Biochemical Pharmacology
|
April 25, 2008
Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases
James P Hardwick
Liver Research
|
June 28, 2019
Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2
Yoon Kwang Lee, Jung Eun Park, Mikang Lee, et al.
Free Radical Biology & Medicine
|
March 5, 2013
Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury
Mohamed A Abdelmegeed, Sehwan Jang, Atrayee Banerjee, et al.
Advances in Pharmacology (San Diego, Calif.)
|
August 3, 2015
Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease
Byoung-Joon Song, Mohammed Akbar, Inho Jo, et al.
Drug Development Research
|
June 30, 2012
Purification and Recognition of Recombinant Mouse P2X(1) Receptors Expressed in a Baculovirus System
Liping Chen, James P Hardwick, Peter McPhie, et al.
PPAR Research
|
March 20, 2010
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
James P Hardwick, Douglas Osei-Hyiaman, Homer Wiland, et al.
Archives of Biochemistry and Biophysics
|
February 12, 2008
Genomic structure and regulation of the rat hepatic CYP4F1 gene by peroxisome proliferators
Ellen Donelson, Liping Chen, Xiaolan Zhang, et al.
Free Radical Biology & Medicine
|
June 23, 2009
Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress
Mohamed A Abdelmegeed, Kwan-Hoon Moon, James P Hardwick, et al.
Biochemical Pharmacology
|
November 19, 2021
CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD)
Nicholas Osborne, Charles Leahy, Yoon-Kwang Lee, et al.
Hepatology Communications
|
February 7, 2018
Hairy and enhancer of split 6 prevents hepatic lipid accumulation through inhibition of <i>Pparg2</i> expression
Jung Eun Park, Mikang Lee, Seong-Chul Kim, et al.
Page
of 3